Title of article
Serpentine Supravenous Hyperpigmentation in an HIV Patient Receiving R-CHOP for DLBCL
Author/Authors
Lancman, Guido Department of Medicine - Icahn School of Medicine at Mount Sinai, New York, NY, USA , steinberg, amir Tisch Cancer Institute -Mount Sinai Hospital, New York, NY, USA , Gabrilove, Janice Tisch Cancer Institute -Mount Sinai Hospital, New York, NY, USA
Pages
3
From page
1
To page
3
Abstract
Serpentine supravenous hyperpigmentation (SSH) is a rare vasculo-cutaneous entity that has been associated with peripheral infusion of chemotherapy agents, in particular 5-FU1-3, but also seen with docetaxel4,5, fotemustine6, and vinorelbine7. It consists of a marked hyperpigmentation along the superficial network of veins proximal to the chemotherapy infusion site and was originally described in a 1976 case report in association with 5-FU1. Here, for the first time, we report SSH in association with R-CHOP chemotherapy.
Keywords
Serpentine supravenous hyperpigmentation , SSH , Chemotherapy , R- CHOP , DLBCL
Journal title
Astroparticle Physics
Serial Year
2018
Record number
2482635
Link To Document